when Arsenal won the 2005 FA Cup Final. Arsenal went on to win the tournament, though Flamini was an unused substitute in the Final, also remaining on the substitutes' bench when Arsenal repeated the feat, becoming FA Cup champions again in 2015. On 23 September 2015, Flamini earned his first start of the 2015–16 season in the Football League Cup third round tie against Tottenham Hotspur. He scored both of Arsenal's goals with a Man of the Match performance. Crystal Palace Flamini signed as a free-agent for Crystal Palace on 8 September 2016. He was released by the club at the end of the 2016–17 season. Getafe On 2 February 2018, Flamini signed for Getafe on a free transfer. He made eight appearances in La Liga before leaving the club at the end of the season. On 18 December 2018, Flamini rejoined Getafe. International career Flamini accepted his first call up to France by coach Raymond Domenech for a friendly against Argentina at the Stade de France on 7 February 2007 after Jérémy Toulalan was ruled out due to injury. He later made his international debut in a friendly against Morocco on 16 November 2007 as a substitute. Style of play A combative, energetic, tactically intelligent, and tenacious midfielder, according to Arsenal manager Arsène Wenger, Flamini is a player with a fantastic work rate, good ball-winning ability and great mentality; he can play anywhere across midfield, in the centre as a box-to-box or defensive midfielder, or on either flank as a cover at full-back. Business career Flamini is a partner of GF Biochemicals, a leading global producer of levulinic acid and derivatives. He has stated that “we founded GFBiochemicals with the ambition of finding sustainable alternatives to oil-based products”. Levulinic acid includes grass or woodchips, and can be used in plastics, solvents, fuels and the pharmaceutical industry. Levulinic acid has been identified by the U.S. Department of Energy as one of the 12 molecules that can help unlock a “greener” world. In addition to GFBiochemicals’ established presence in the Netherlands and headquarters in Italy, Flamini has named China and Brazil as potential new markets for expansion. In 2016, GFBiochemicals fully controls the Segetis, the leading producer of levulinic acid derivatives, in a move towards downstream integration. Segitis was previously owned by Sabic, DSM, and Kosla Ventures, among other entities, and has invested in R&D over the past decade. In 2017,